138 related articles for article (PubMed ID: 32104996)
1. Long-term follow-up results of patients with ADCK4 mutations who have been diagnosed in the asymptomatic period: effects of early initiation of CoQ10 supplementation.
Atmaca M; Gülhan B; Atayar E; Bayazıt AK; Candan C; Arıcı M; Topaloğlu R; Özaltın F
Turk J Pediatr; 2019; 61(5):657-663. PubMed ID: 32104996
[TBL] [Abstract][Full Text] [Related]
2. Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment.
Atmaca M; Gulhan B; Korkmaz E; Inozu M; Soylemezoglu O; Candan C; Bayazıt AK; Elmacı AM; Parmaksiz G; Duzova A; Besbas N; Topaloglu R; Ozaltin F
Pediatr Nephrol; 2017 Aug; 32(8):1369-1375. PubMed ID: 28337616
[TBL] [Abstract][Full Text] [Related]
3. Early-onset COQ8B (ADCK4) glomerulopathy in a child with isolated proteinuria: a case report and literature review.
Zhai SB; Zhang L; Sun BC; Zhang Y; Ma QS
BMC Nephrol; 2020 Sep; 21(1):406. PubMed ID: 32957916
[TBL] [Abstract][Full Text] [Related]
4. Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency.
Drovandi S; Lipska-Ziętkiewicz BS; Ozaltin F; Emma F; Gulhan B; Boyer O; Trautmann A; Xu H; Shen Q; Rao J; Riedhammer KM; Heemann U; Hoefele J; Stenton SL; Tsygin AN; Ng KH; Fomina S; Benetti E; Aurelle M; Prikhodina L; Schreuder MF; Tabatabaeifar M; Jankowski M; Baiko S; Mao J; Feng C; Liu C; Sun S; Deng F; Wang X; Clavé S; Stańczyk M; Bałasz-Chmielewska I; Fila M; Durkan AM; Levart TK; Dursun I; Esfandiar N; Haas D; Bjerre A; Anarat A; Benz MR; Talebi S; Hooman N; Ariceta G; ; ; ; Schaefer F
Kidney Int; 2022 Sep; 102(3):604-612. PubMed ID: 35643375
[TBL] [Abstract][Full Text] [Related]
5. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.
Ashraf S; Gee HY; Woerner S; Xie LX; Vega-Warner V; Lovric S; Fang H; Song X; Cattran DC; Avila-Casado C; Paterson AD; Nitschké P; Bole-Feysot C; Cochat P; Esteve-Rudd J; Haberberger B; Allen SJ; Zhou W; Airik R; Otto EA; Barua M; Al-Hamed MH; Kari JA; Evans J; Bierzynska A; Saleem MA; Böckenhauer D; Kleta R; El Desoky S; Hacihamdioglu DO; Gok F; Washburn J; Wiggins RC; Choi M; Lifton RP; Levy S; Han Z; Salviati L; Prokisch H; Williams DS; Pollak M; Clarke CF; Pei Y; Antignac C; Hildebrandt F
J Clin Invest; 2013 Dec; 123(12):5179-89. PubMed ID: 24270420
[TBL] [Abstract][Full Text] [Related]
6. Early-onset of ADCK4 glomerulopathy with renal failure: a case report.
Lolin K; Chiodini BD; Hennaut E; Adams B; Dahan K; Ismaili K
BMC Med Genet; 2017 Mar; 18(1):28. PubMed ID: 28298181
[TBL] [Abstract][Full Text] [Related]
7. COQ8B nephropathy: Early detection and optimal treatment.
Song X; Fang X; Tang X; Cao Q; Zhai Y; Chen J; Liu J; Zhang Z; Xiang T; Qian Y; Wu B; Wang H; Zhou W; Liu C; Shen Q; Xu H; Rao J
Mol Genet Genomic Med; 2020 Aug; 8(8):e1360. PubMed ID: 32543055
[TBL] [Abstract][Full Text] [Related]
8. Focal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations.
Park E; Kang HG; Choi YH; Lee KB; Moon KC; Jeong HJ; Nagata M; Cheong HI
Pediatr Nephrol; 2017 Sep; 32(9):1547-1554. PubMed ID: 28405841
[TBL] [Abstract][Full Text] [Related]
9. Coenzyme Q10 supplementation therapy for 2 children with proteinuria renal disease and ADCK4 mutation: Case reports and literature review.
Feng C; Wang Q; Wang J; Liu F; Shen H; Fu H; Mao J
Medicine (Baltimore); 2017 Nov; 96(47):e8880. PubMed ID: 29382012
[TBL] [Abstract][Full Text] [Related]
10. Long-term nephrotic syndrome recurrence risk of kidney transplantation in two siblings with ADCK4-associated glomerulopathy.
Wang S; Zhao F; Li L; Yu Z
Pediatr Transplant; 2022 Feb; 26(1):e14143. PubMed ID: 34605136
[TBL] [Abstract][Full Text] [Related]
11. Response to Early Coenzyme Q10 Supplementation Is not Sustained in CoQ10 Deficiency Caused by CoQ2 Mutation.
Eroglu FK; Ozaltin F; Gönç N; Nalçacıoğlu H; Özçakar ZB; Yalnızoğlu D; Güçer Ş; Orhan D; Eminoğlu FT; Göçmen R; Alikaşifoğlu A; Topaloğlu R; Düzova A
Pediatr Neurol; 2018 Nov; 88():71-74. PubMed ID: 30337132
[TBL] [Abstract][Full Text] [Related]
12. ADCK4 "reenergizes" nephrotic syndrome.
Malaga-Dieguez L; Susztak K
J Clin Invest; 2013 Dec; 123(12):4996-9. PubMed ID: 24270414
[TBL] [Abstract][Full Text] [Related]
13. Urinary coenzyme Q10 as a diagnostic biomarker and predictor of remission in a patient with ADCK4-associated Glomerulopathy: a case report.
Zhang Y; Liao X; Jiang Y; Lv X; Yu Y; Dai Q; Ao L; Tao L; Peng Z
BMC Nephrol; 2021 Jan; 22(1):11. PubMed ID: 33413146
[TBL] [Abstract][Full Text] [Related]
14. A novel ADCK4 mutation in a Chinese family with ADCK4-Associated glomerulopathy.
Yang J; Yang Y; Hu Z
Biochem Biophys Res Commun; 2018 Nov; 506(3):444-449. PubMed ID: 30352687
[TBL] [Abstract][Full Text] [Related]
15. [Coenzyme Q(10) treatment for one child with COQ6 gene mutation induced nephrotic syndrome and literature review].
Cao Q; Li GM; Xu H; Shen Q; Sun L; Fang XY; Liu HM; Guo W; Zhai YH; Wu BB
Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):135-138. PubMed ID: 28173653
[No Abstract] [Full Text] [Related]
16. ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS.
Korkmaz E; Lipska-Ziętkiewicz BS; Boyer O; Gribouval O; Fourrage C; Tabatabaei M; Schnaidt S; Gucer S; Kaymaz F; Arici M; Dinckan A; Mir S; Bayazit AK; Emre S; Balat A; Rees L; Shroff R; Bergmann C; Mourani C; Antignac C; Ozaltin F; Schaefer F;
J Am Soc Nephrol; 2016 Jan; 27(1):63-8. PubMed ID: 25967120
[TBL] [Abstract][Full Text] [Related]
17. ADCK4 Deficiency Destabilizes the Coenzyme Q Complex, Which Is Rescued by 2,4-Dihydroxybenzoic Acid Treatment.
Widmeier E; Yu S; Nag A; Chung YW; Nakayama M; Fernández-Del-Río L; Hugo H; Schapiro D; Buerger F; Choi WI; Helmstädter M; Kim JW; Ryu JH; Lee MG; Clarke CF; Hildebrandt F; Gee HY
J Am Soc Nephrol; 2020 Jun; 31(6):1191-1211. PubMed ID: 32381600
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of one infantile nephrotic syndrome caused by COQ2 gene mutation and literature review].
Xu K; Mao XY; Yao Y; Cheng H; Zhang XJ
Zhonghua Er Ke Za Zhi; 2018 Sep; 56(9):662-666. PubMed ID: 30180404
[No Abstract] [Full Text] [Related]
19.
Li M; Yue Z; Lin H; Wang H; Chen H; Sun L
Ren Fail; 2021 Dec; 43(1):97-101. PubMed ID: 33397173
[TBL] [Abstract][Full Text] [Related]
20. Primary coenzyme Q10 nephropathy, a potentially treatable form of steroid-resistant nephrotic syndrome.
Tan W; Airik R
Pediatr Nephrol; 2021 Nov; 36(11):3515-3527. PubMed ID: 33479824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
